![Younok Dumortier Shin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Younok Dumortier Shin
Plus aucun poste en cours
Profil
Younok Dumortier Shin served as Vice President & Managing Director at Dermelix Biotherapeutics, LLC.
She was also the Chief Technology Officer at Avalo Therapeutics, Inc. from 2020 to 2022.
She holds a graduate and doctorate degree from McGill University, an MBA from Babson College, and an undergraduate degree from the University of British Columbia.
Anciens postes connus de Younok Dumortier Shin
Sociétés | Poste | Fin |
---|---|---|
AVALO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2022 |
Dermelix Biotherapeutics, Llc
![]() Dermelix Biotherapeutics, Llc Miscellaneous Commercial ServicesCommercial Services Dermelix Biotherapeutics, LLC is a non-clinical stage biopharmaceutical company that specializes in developing treatments for patients with rare genetic skin diseases. Dermelix Biotherapeutics is based in Albany, NY. The private company's focus is on delivering effective therapies to those who suffer from these conditions. | Corporate Officer/Principal | - |
Formation de Younok Dumortier Shin
McGill University | Doctorate Degree |
Babson College | Masters Business Admin |
University of British Columbia | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
AVALO THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Dermelix Biotherapeutics, Llc
![]() Dermelix Biotherapeutics, Llc Miscellaneous Commercial ServicesCommercial Services Dermelix Biotherapeutics, LLC is a non-clinical stage biopharmaceutical company that specializes in developing treatments for patients with rare genetic skin diseases. Dermelix Biotherapeutics is based in Albany, NY. The private company's focus is on delivering effective therapies to those who suffer from these conditions. | Commercial Services |